Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
absorption, Acknowledgment, Addendum, Alsup, Annex, appended, attorney, Aug, Aziz, banking, behavior, black, blood, Blvd, Brett, Burton, Chairman, CIO, CODM, compensatory, confirmatory, Cowen, cybersecurity, Dean, Deepika, DEF, dismissed, dividend, dupilumab, Dupixent, East, ensifentrine, eosinophilic, ERM, Erroneously, estate, Evergreen, expiratory, Farnum, filer, GlaxoSmithKline, GP, Graham, grew, Grimaud, Hatch, hereof, history, HMS, ICS, incident, Indemnity, Indiana, Inline, instability, Institute, intelligence, intrusion, IOS, Iowa, iXBRL, Jeremy, labor, Lastly, Laurie, lawfully, length, lodge, mAb, maker, Malkiel, Mitchell, Montana, nasal, necessity, overpayment, overseeing, Pakianathan, payer, permissible, pharmacoeconomic, predetermined, prompt, prurigo, quantify, questioning, ratifying, real, Regeneron, reprice, resubstitution, Rhonda, Richard, Sanofi, Sawaf, sector, sheltered, shipping, slightly, SOC, Specimen, stead, subsided, substitute, substitution, Sunovion, supplementary, Tennessee, thereunto, therewith, thing, transferee, transferor, trough, Unadjusted, uncontrolled, undersigned, undertook, upper, vacant, venue, Verona, Vice, virtue, Waiver, warehoused, warehousing, Waxman, withdrew, XBRL, yearly, yield, YUPERLI
Removed:
aid, Arca, attempt, attest, bifurcation, Biotech, broken, capitalized, categorized, caution, closure, coinciding, collaborator, consistency, continually, Coupon, Crohn, defective, Dettmer, discovered, disposition, documentation, dysfunction, embedded, emerge, Ernst, favorably, forfeiture, Franklin, freely, graph, Gunderson, Hachigian, hedging, hypothetical, incorporate, inflammatory, instrument, intestinal, JAKi, Janssen, Jr, landscape, lapse, lesser, leveraged, LLP, macroeconomic, maximize, mechanism, Millennium, minimize, misinterpretation, Notwithstanding, NYSE, obtainable, paramount, paydown, permit, pertain, posed, prescribed, reinvestment, remote, rest, Robert, RR, RSA, scaled, shield, shortage, spread, spreading, Stough, suffering, supplement, suspended, Takeda, tangible, thereon, toxicology, traditionally, trajectory, tranche, travel, underwriting, unqualified, vaccine, Villeneuve, Woodford, Young
Filing tables
Filing exhibits
Related press release
Associated TBPH transcripts
TBPH similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
1. | Registration Statements (Form S-8 Nos. 333-198206, 333-202856, 333-210225, 333-216446, 333-223470, 333-231559, 333-236868 and 333-253894) pertaining to the Theravance Biopharma, Inc. 2013 Equity Incentive Plan and the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan, and |
2. | Registration Statement (Form S-8 No. 333-200225) pertaining to the Theravance Biopharma, Inc. 2014 New Employee Equity Incentive Plan; |
of our report dated March 1, 2024, with respect to the consolidated financial statements of Theravance Biopharma, Inc. included in this Annual Report (Form 10-K) of Theravance Biopharma, Inc. for the year ended December 31, 2023.
/s/ Ernst & Young LLP
San Mateo, California
March 1, 2024